NSE: HCG | BSE: 539787

Mid-range Performer

Download real time

639.35 -13.05 (-2.00%)

High volume today

NSE 09 Jan, 2026 3:31 PM (IST)

9,014.8

Market Cap

Below industry Median

Beta 1Year

Very Low volatility

Healthcare Global Enterprises Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for HCG, BSE:539787 Healthcare Global Enterprises Ltd.

Search Inside the pdf :

Healthcare Global Enterprises Ltd.

05 Dec 2025

639.35

-2.00%

Company Update:Health.Global

Buy: Healthcare Global Enterpri...

Axis Direct

We retain our BUY rating on the stock with a target price of Rs 850/share, implying an upside potential of 19% from the CMP.

Healthcare Global Enterprises Ltd. is trading above its 200 day SMA of 632.0

Healthcare Global Enterprises Ltd.

02 Dec 2025

639.35

-2.00%

HEALTHCARE GLOBAL ENTERPRISES LIMITED

Accumulate: Healthcare Global Enterpri...

Target

Geojit BNP Paribas

HCG is well-positioned to deliver strong revenue growth over the next 23 years, driven by improving ARPOB and continued bed additions. However, profitability recovery is expected to be gradual due to the debt-funded nature of recent capital expenditure. The management's plan for a capital infusion is likely to ease the interest burden. With KKR as the new promoter, the company is set for a transformative phase that should enhance growth and operational efficiency. We, therefore upgrade our rating to Accumulate with...

Healthcare Global has gained 31.53% in the last 1 Year

Healthcare Global Enterprises Ltd.

14 Nov 2025

639.35

-2.00%

Result Update:Health.Global

Buy: Healthcare Global Enterpri...

Target

Axis Direct

We maintain our BUY recommendation on the stock.

Healthcare Global Enterprises Ltd. is trading at high day volume of 396.0K.

Healthcare Global Enterprises Ltd.

04 Oct 2025

639.35

-2.00%

Pick of the Week:Health.Global

Buy: Healthcare Global Enterpri...

Target

Axis Direct

BUY with a target price of Rs 702 implying an upside of 10% from the CMP

Institutional Investors have increased holdings from 15.38% to 21.95% in Sep 2025 qtr.

Healthcare Global Enterprises Ltd.

29 Aug 2025

639.35

-2.00%

HEALTHCARE GLOBAL ENTERPRISES LIMITED

Hold: Healthcare Global Enterpri...

Target

Geojit BNP Paribas

HCG is poised to deliver strong top-line growth over the next 23 years, supported by improvements in ARPOB and ongoing bed additions. However, profitability recovery may be gradual given the debt-funded nature of recent capex. Management has indicated plans for a capital infusion, which could help ease the interest burden. With KKR as the new promoter, the business is expected to undergo transformation, enhancing growth and operational efficiencies. Considering the elevated debt levels, we retain our Hold...

Healthcare Global En.. has an average target of 724.50 from 4 brokers.

Healthcare Global Enterprises Ltd.

05 Aug 2025

639.35

-2.00%

Result Update:Health.Global

Buy: Healthcare Global Enterpri...

Target

Axis Direct

We maintain our BUY recommendation on the stock.

Institutional Investors have increased holdings from 15.38% to 21.95% in Sep 2025 qtr.

Healthcare Global Enterprises Ltd.

05 Aug 2025

639.35

-2.00%

Decent quarter, occupancy may have hit a trough

Hold: Healthcare Global Enterpri...

Target

ICICI Securities Limited

HealthCare Global Enterprises’ (HCG) Q1FY26 result was in line with our expectations. Revenue grew 16.7% YoY driven by new centres in Mumbai (+28% YoY), Kolkata (+17% YoY) and Ahmedabad (+22% YoY) while key cluster of Karnataka and East India grew at a moderate pace.

Healthcare Global Enterprises Ltd. is trading below its 30 day SMA of 691.1

Healthcare Global Enterprises Ltd.

28 Jun 2025

639.35

-2.00%

Pick of the Week:Health.Global

Buy: Healthcare Global Enterpri...

Target

Axis Direct

We recommend a BUY with TP of Rs 600, implying an upside of 10% from the CMP.

Healthcare Global En.. has an average target of 724.50 from 4 brokers.

Healthcare Global Enterprises Ltd.

27 May 2025

639.35

-2.00%

Result Update:Health.Global

Buy: Healthcare Global Enterpri...

Target

Axis Direct

We maintain our BUY recommendation on the stock.

Healthcare Global En.. has an average target of 724.50 from 4 brokers.

Healthcare Global Enterprises Ltd.

27 May 2025

639.35

-2.00%

HealthCare Global Enterprises (HCG IN) Q4FY25 Result Update ...

Buy: Healthcare Global Enterpri...

Target

Prabhudas Lilladhar

HealthCare Global Enterprises' (HCG) Q4 consolidated EBITDA grew by 15% YoY to Rs1.1bn; in line with our estimate. The company's asset-light approach with a focus on partnerships has made its business model more capital efficient and scalable, in our view. We believe the strategic investment by KKR will bring in more operational and financial efficiency. Currently, HCG enjoys 13-14% pre IND AS margin, which is lower than its peers. We expect KKR to drive growth through bed expansion, rationalization of existing assets and scale up of...

Institutional Investors have increased holdings from 15.38% to 21.95% in Sep 2025 qtr.

Is Healthcare Global Enterprises Ltd. worth buying?

46 Votes:

Buy 73.91%

Sell 13.04%

Hold 13.04%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Accumulate SEE REPORTS >

pdf